SILO Pharma Inc (NASDAQ: SILO)’s stock price has dropped by -10.57 in relation to previous closing price of 1.23. Nevertheless, the company has seen a loss of -6.78% in its stock price over the last five trading days. globenewswire.com reported 2024-10-31 that The implant demonstrates stability and consistent drug release, supporting further analytical testing and development SARASOTA, FL, Oct. 31, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced promising results from recent sterilization and dissolution tests of its SP-26 ketamine-loaded implant for fibromyalgia and chronic pain. These tests were conducted under the Company’s current development agreement with Sever Pharma Solutions.
Is It Worth Investing in SILO Pharma Inc (NASDAQ: SILO) Right Now?
Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SILO is 4.30M and currently, short sellers hold a 2.37% of that float. On November 14, 2024, SILO’s average trading volume was 169.67K shares.
SILO’s Market Performance
SILO stock saw a decrease of -6.78% in the past week, with a monthly decline of -1.85% and a quarterly a decrease of -19.12%. The volatility ratio for the week is 13.96%, and the volatility levels for the last 30 days are 9.19% for SILO Pharma Inc (SILO). The simple moving average for the past 20 days is -5.98% for SILO’s stock, with a -27.07% simple moving average for the past 200 days.
SILO Trading at -1.50% from the 50-Day Moving Average
After a stumble in the market that brought SILO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -75.56% of loss for the given period.
Volatility was left at 9.19%, however, over the last 30 days, the volatility rate increased by 13.96%, as shares sank -5.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.65% lower at present.
During the last 5 trading sessions, SILO fell by -6.78%, which changed the moving average for the period of 200-days by -28.57% in comparison to the 20-day moving average, which settled at $1.1699. In addition, SILO Pharma Inc saw -23.61% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SILO starting from Weisblum Eric, who purchase 4,438 shares at the price of $1.11 back on Jun 12 ’24. After this action, Weisblum Eric now owns 180,432 shares of SILO Pharma Inc, valued at $4,926 using the latest closing price.
Weisblum Eric, the CEO and President of SILO Pharma Inc, purchase 562 shares at $1.08 during a trade that took place back on Jun 11 ’24, which means that Weisblum Eric is holding 175,994 shares at $607 based on the most recent closing price.
Stock Fundamentals for SILO
Current profitability levels for the company are sitting at:
- -56.25 for the present operating margin
- -3.72 for the gross margin
The net margin for SILO Pharma Inc stands at -52.47. The total capital return value is set at 5.48. Equity return is now at value -48.34, with -37.69 for asset returns.
Currently, EBITDA for the company is -3.63 million with net debt to EBITDA at 1.22. When we switch over and look at the enterprise to sales, we see a ratio of 1.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.84.
Conclusion
To wrap up, the performance of SILO Pharma Inc (SILO) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
